|POZEN to Present at Upcoming Investor Conferences|
CHAPEL HILL, N.C., Sep 12, 2003 (BUSINESS WIRE) -- POZEN Inc. (NASDAQ: POZN) announced today that POZEN will be presenting to investors at two upcoming conferences.
Matthew E. Czajkowski the company's chief financial officer, will be speaking at the ThinkEquity Growth Conference on Wednesday, September 17, at 10:30 a.m. Eastern Time.
John R. Plachetka, Pharm.D., the company's chairman, president and chief executive officer, will be speaking to investors at the UBS Global Life Sciences Conference on Wednesday, September 24, at 8:30 a.m. Eastern Time. Dr. Plachetka's presentation will be webcast live and archived on POZEN's home page at www.pozen.com.
POZEN is a pharmaceutical company developing therapeutic advancements in a cost effective manner. Product development efforts are focused on diseases with unmet medical needs where POZEN can improve efficacy, safety, and/or patient convenience. Since its inception, POZEN has developed the largest and most advanced product pipeline in the field of migraine. POZEN has development and commercial alliances with GlaxoSmithKline, Xcel, and Nycomed. The company's common stock is traded on The Nasdaq Stock Market under the symbol "POZN". For detailed company information, including copies of this and other press releases, see POZEN's website: www.pozen.com.